Formulation and Ex Vivo Evaluation of Ivermectin Within Different Nano-Drug Delivery Vehicles for Transdermal Drug Delivery
<b>Background/Objectives:</b> Ivermectin gained widespread attention as the “miracle drug” during the coronavirus disease 2019 (COVID-19) pandemic. Its inclusion in the 21st World Health Organization (WHO) List of Essential Medicines is attributed to its targeted anti-helminthic response...
Saved in:
| Main Authors: | Eunice Maureen Steenekamp, Wilna Liebenberg, Hendrik J. R. Lemmer, Minja Gerber |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/16/11/1466 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Penetration enhancer containing vesicles for dermal and transdermal drug delivery. A review
by: Fatma A. Sarhan, et al.
Published: (2023-12-01) -
Transdermal patches: Design and current approaches to painless drug delivery
by: Al Hanbali Othman A., et al.
Published: (2019-06-01) -
Nanocarrier-Based Transdermal Drug Delivery Systems for Dermatological Therapy
by: Yunxiang Kang, et al.
Published: (2024-10-01) -
Design Principles and Applications of Ionic Liquids for Transdermal Drug Delivery
by: Sai Gao, et al.
Published: (2024-11-01) -
Formulation and Development of Ethosomal Drug Delivery System of Silymarin for Transdermal Application
by: Yasir Q. almajidi, et al.
Published: (2024-12-01)